- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
SEBI imposes Rs 1 lakh fine on Fortis Healthcare Holdings for disclosure lapses
Sebi found that Fortis Healthcare Holdings had failed to make timely disclosures about the change in shareholding in the prescribed format and has thereby violated the provision of Substantial Acquisition of Shares and Takeover (SAST) Regulations.
New Delhi: Markets regulator Sebi on Monday slapped a Rs 1 lakh fine on Fortis Healthcare Holdings, the erstwhile promoter entity of Fortis Healthcare Ltd for disclosure lapses.
Sebi found that Fortis Healthcare Holdings had failed to make timely disclosures about the change in shareholding in the prescribed format and has thereby violated the provision of Substantial Acquisition of Shares and Takeover (SAST) Regulations.
The regulator noted that the shareholding of the former promoter entity decreased in Fortis Healthcare Ltd in 2017 following the sale of shares.
Sebi observed that promoters' shareholding in Fortis Healthcare Ltd (target company) was 39.82 percent as on July 18, 2017, in which Fortis Healthcare Holdings'' stake was 39.71 percent.
Subsequently, pursuant to the sale of shares of the target company by Fortis Healthcare Holdings during July 19-27, 2017, the stake of Fortis Healthcare Holdings and promoters in the target company decreased to 37.60 percent and 37.7 percent, respectively, on July 27, 2017.
Since this change in shareholding was more than 2 percent, it required disclosure to be made by the holding company under the regulatory norms.
"I note that the noticee had failed to make timely disclosures in the prescribed format and has thereby violated ...SEBI SAST Regulations, 2011," Sebi Adjudicating Officer G Ramar said in its order.
Fortis Healthcare Holdings is the noticee.
Read also: Delhi HC allows SFIO to interrogate Ex- Fortis promoters for two weeks
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751